Spanish CDMO adapts production capabilities, boosts workforce to meet rising viral vector demand 27-Jun-2022 By Jane Byrne VIVEbiotech has completed the latest expansion phase of its lentiviral vector manufacturing capabilities; the development is aimed at alleviating the viral vector bottleneck for advanced therapies.